He recalls a border collie who chased shadows obsessively, spinning in circles for hours. The owners thought it was a quirk. A veterinary behaviorist diagnosed canine compulsive disorder with an underlying thyroiditis. Within a week of starting levothyroxine, the shadow-chasing dropped by 90%.
She ran a full panel—CBC, chemistry, thyroid, and a bile acid test for liver function. The results came back an hour later. Gus had a portosystemic shunt: a congenital blood vessel defect that was allowing toxins from his gut to bypass the liver and accumulate in his brain.
We were wrong.
A 2023 study in the Journal of Veterinary Internal Medicine found that when behavior-modifying drugs (like fluoxetine or trazodone) are combined with targeted medical diagnostics and environmental modification, success rates for resolving aggression, anxiety, and compulsive disorders rise from roughly 40% to nearly 85%. HOT-ZooskoolVixenTripToTie
But Dr. Elena Vasquez, a board-certified veterinary behaviorist, didn’t reach for a prescription pad or a muzzle. Instead, she knelt on the linoleum floor and watched Gus breathe. His flanks were moving too fast. His eyes, though soft, had a pinched look at the corners. She pressed her palm gently against his ribs.
The drugs don’t “zombify” the animal. They lower the volume of the fear response just enough that the brain can learn a new song. Perhaps the hardest part of the work is not treating the animal—it’s retraining the human.
“His heart rate is elevated,” she said. “Not panic-level. But it’s not rest.” He recalls a border collie who chased shadows
When a dog or cat experiences chronic low-grade stress—a loud household, inconsistent handling, the presence of a territorial rival—their body floods with cortisol. Over weeks and months, that cortisol damages the hippocampus, the brain region responsible for learning and memory. The animal becomes trapped in a loop: it cannot learn new safety cues because the part of the brain required for that learning is inflamed.
The couch is safe now. And so is Gus. J. Foster writes about the intersection of animal welfare and clinical science. This feature is based on interviews with practicing veterinary behaviorists and peer-reviewed literature as of 2026.
“The owners cried,” Thorne says. “They had spent two years yelling ‘No!’ at a dog who was having a medical meltdown. They felt like monsters. But they weren’t. They just didn’t know what we now know.” As Gus the Labrador recovered from his shunt surgery—a delicate procedure that rerouted his blood flow—his owners noticed something strange. He stopped guarding his food bowl. He began wagging his tail when the mailman arrived instead of barking. He even started playing with a plush duck toy, something he hadn’t done since he was a puppy. Within a week of starting levothyroxine, the shadow-chasing
The Labrador retriever, a sturdy yellow named Gus, arrived at the clinic on a Tuesday. To the untrained eye, he was a textbook case of “bad behavior.” For three months, he had been destroying his owners’ couch—not just chewing the cushions, but methodically shredding the armrests, always between the hours of 2:00 and 4:00 PM.
This is called “cooperative care,” and it is transforming outcomes.
The treatment wasn’t Prozac or a rehoming ad. It was a root canal. Three weeks later, Luna was sleeping at the foot of the crib. The most radical shift in veterinary behavior, however, concerns fear. We now know that fear is not just an emotion; it is a metabolic event.